News
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
1d
GB News on MSNWeight loss jabs could be key to shrinking breast cancer tumours as scientists discover dual benefitA weight loss drug has been found to dramatically reduce breast cancer tumour growth while still achieving significant weight ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results